Advanced search
Publication Cover
Ophthalmic Epidemiology Volume 30, 2023 - Issue 4
Submit an article Journal homepage
116
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Seroprevalence of SARS-CoV-2 in Mexican Health Care Workers after Two Years of the Pandemic: The Picture of an Ophthalmic Medical Centre

Yonathan Garfiasa Research Unit, Institute of Ophthalmology, Conde de Valenciana Foundation. Chimalpopoca, Mexico, Mexico;b Department of Biochemistry, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico, MexicoCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3753-1035View further author information
ORCID Icon,
Fátima Sofía Magaña-Guerreroa Research Unit, Institute of Ophthalmology, Conde de Valenciana Foundation. Chimalpopoca, Mexico, MexicoORCID Iconhttps://orcid.org/0000-0002-1535-9898View further author information
ORCID Icon,
Beatriz Buentello-Volantea Research Unit, Institute of Ophthalmology, Conde de Valenciana Foundation. Chimalpopoca, Mexico, MexicoORCID Iconhttps://orcid.org/0000-0003-4529-990XView further author information
ORCID Icon,
Itayetzin Beurini Cruz Vegaa Research Unit, Institute of Ophthalmology, Conde de Valenciana Foundation. Chimalpopoca, Mexico, MexicoView further author information
,
Ilse Castro Salasa Research Unit, Institute of Ophthalmology, Conde de Valenciana Foundation. Chimalpopoca, Mexico, MexicoView further author information
,
Paola de Jesús Sánchez Cisnerosa Research Unit, Institute of Ophthalmology, Conde de Valenciana Foundation. Chimalpopoca, Mexico, MexicoView further author information
,
José Eduardo Aguayo Floresa Research Unit, Institute of Ophthalmology, Conde de Valenciana Foundation. Chimalpopoca, Mexico, MexicoView further author information
,
Angel Gustavo Salas Laisc Coordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguro Social, IMSS, Ciudad de México, MexicoORCID Iconhttps://orcid.org/0000-0003-3757-6209View further author information
ORCID Icon,
José Esteban Muñoz Medinad Coordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguro Social, Mexico CityMexicoORCID Iconhttps://orcid.org/0000-0002-1289-4457View further author information
ORCID Icon,
Verónica Mata-Haroe Laboratorio de Microbiología e Inmunología, Centro de Investigación en Alimentación y Desarrollo A. C. (CIAD), Hermosillo, MexicoView further author information
,
Mónica Reséndiz-Sandovalf Laboratorio de Inmunología, Centro de Investigación en Alimentación y Desarrollo, A.C. (CIAD), Hermosillo, MexicoView further author information
,
Verónica A Vázquez-Garcíaf Laboratorio de Inmunología, Centro de Investigación en Alimentación y Desarrollo, A.C. (CIAD), Hermosillo, MexicoView further author information
&
Jesús Hernándezf Laboratorio de Inmunología, Centro de Investigación en Alimentación y Desarrollo, A.C. (CIAD), Hermosillo, MexicoCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5131-3600View further author information
ORCID Icon show all
Pages 400-406 | Received 25 Jun 2022, Accepted 19 Sep 2022, Published online: 02 Oct 2022

References

  • Tao ZY, Dong J, Culleton R. The use of facemasks may not lead to an increase in hand-face contact. Transbound Emerg Dis. 2020;67:3038–3040. doi:10.1111/tbed.13698.
  • Altmann DM, Boyton RJ. COVID-19 vaccination: the road ahead. Science. 2022;375:1127–1132. doi:10.1126/science.abn1755.
  • Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2021;21:73–82. doi:10.1038/s41577-020-00480-0.
  • COFEPRIS-México. Vacunas autorizadas en México. 2021. https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-sinopharm?idiom=es. Accessed June 15, 2022.
  • Doroftei B, Ciobica A, Ilie OD, Maftei R, Ilea C. Mini-review discussing the reliability and efficiency of COVID-19 vaccines. Diagnostics (Basel). 2021;11(4):579.
  • Gomez-Ochoa SA, Franco OH, Rojas LZ, et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol. 2021;190:161–175. doi:10.1093/aje/kwaa191.
  • Matos AG, Sarquis IC, Santos AAN, LP C. COVID-19: risk of ocular transmission in health care professionals. Rev Bras Med Trab. 2021;19:82–87. doi:10.47626/1679-4435-2021-598.
  • Vacunacovid.Gob.Mx. Vacunación en México. 2021. http://vacunacovid.gob.mx/wordpress/. Accessed July 19, 2021.
  • Magana-Guerrero FS, Trujillo DH, Buentello-Volante B, et al. SARS-CoV-2 seroprevalence among the health care staff of an ophthalmological reference centre, a cross sectional study. Ophthalmic Epidemiol. 2021:1–8. doi:10.1080/09286586.2021.1974493.
  • Bonelli F, Sarasini A, Zierold C, et al. Clinical and analytical performance of an automated serological test that identifies S1/S2-Neutralizing IgG in COVID-19 patients semiquantitatively. J Clin Microbiol. 2020;58. doi:10.1128/JCM.01224-20.
  • Tan CW, Chia WN, Qin X, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction. Nat Biotechnol. 2020;38:1073–1078. doi:10.1038/s41587-020-0631-z.
  • Ebinger JE, Fert-Bober J, Printsev I, et al. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. Nat Med. 2021;27:981–984. doi:10.1038/s41591-021-01325-6.
  • Otiti-Sengeri J, Andrew OB, Lusobya RC, et al. High COVID-19 vaccine acceptance among eye healthcare workers in Uganda. Vaccines (Basel). 2022;10. doi:10.3390/vaccines10040609.
  • Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1412–1423. doi:10.1056/NEJMoa2101765.
  • Feikin DR, Higdon MM, Abu-Raddad LJ, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399:924–944. doi:10.1016/S0140-6736(22)00152-0.
  • Bongiovanni M, Liuzzi G, Schiavon L, Gianturco L, Giuliani G. Evaluation of the immune response to COVID-19 vaccine mRNA BNT162b2 and correlation with previous COVID-19 infection. J Clin Virol. 2021;143:104962. doi:10.1016/j.jcv.2021.104962.
  • Goldberg Y, Mandel M, Bar-On YM, et al. Protection and waning of natural and hybrid immunity to SARS-CoV-2. N Engl J Med. 2022;386:2201–2212. doi:10.1056/NEJMoa2118946.
  • Hall V, Foulkes S, Insalata F, et al. Protection against SARS-CoV-2 after covid-19 vaccination and previous infection. N Engl J Med. 2022;386:1207–1220. doi:10.1056/NEJMoa2118691.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.